NR3C2 and endothelial dysfunction: We and others demonstrated that aldosterone, through mineralocorticoid receptor (MR) activation, is involved in the regulation of structural and functional vascular changes, in particular in endothelial dysfunction and vascular hypercontractility, often associated with obesity-related type 2 diabetes and hypertension.